Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial

Satti I., Marshall JL., Harris SA., Wittenberg R., Tanner R., Lopez Ramon R., Wilkie M., Ramos Lopez F., Riste M., Wright D., Peralta Alvarez MP., Williams N., Morrison H., Stylianou E., Folegatti P., Jenkin D., Vermaak S., Rask L., Cabrera Puig I., Powell Doherty R., Lawrie A., Moss P., Hinks T., Bettinson H., McShane H.

DOI

10.1016/s1473-3099(24)00143-9

Type

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

04/2024

Permalink Original publication